Login / Signup

Unusual high prevalence of antibodies to hepatitis E virus in South Brazil.

Renata ZorzettoRafaela Luiza KleinLuana Marina Sheer ErpenBárbara Diel KleinIgor GiacobboRafael Arrua da SilveiraRafael FrandolosoLuiz Carlos Kreutz
Published in: FEMS microbiology letters (2021)
Hepatitis E virus (HEV) is worldwide distributed and might cause acute or chronic hepatitis mainly in immunocompromised individuals. In previous studies we found a high prevalence of antibodies to HEV within blood donors in south Brazil and also within backyard-raised pigs. Here, we aimed to investigate the prevalence of anti-HEV antibody and HEV RNA within the general population from three major municipalities (Caxias do Sul, Passo Fundo and Santa Maria) in south Brazil. A total of 3000 blood samples were randomly obtained from clinical laboratories at each of the three municipality (n = 1000 each) to determine the presence of anti-HEV antibodies and HEV RNA. Overall, anti-HEV antibodies were detected in 574/1000 (57,4%) samples in Caxias do Sul, 655/1000 (65.5%) samples in Passo Fundo and 554/1000 (55.4%) samples in Santa Maria. The prevalence of HEV-positive samples increased steadily and significantly (P < 0,001) with age and was unusually higher within individual over 40 years. Despite of this, none of the pooled serum samples had detectable levels of HEV RNA. The high anti-HEV antibody prevalence suggests that the virus might be present on the environment and/or foodstuff and poses a permanent threat to immune-compromised individuals.
Keyphrases
  • risk factors
  • intensive care unit
  • respiratory failure
  • liver failure
  • drug induced
  • hepatitis b virus